Market Cap
GlaxoSmithKline plc Market Capitalization:
£56.92 Billion
GBP as of July 1, 2023
US$72.32 Billion
GlaxoSmithKline plc Main Stock Listing
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—General
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$417.05 B |
|
Johnson & Johnson
|
$412.24 B |
|
Merck
|
$275.82 B |
Roche
|
$241.08 B |
|
AbbVie
|
$239.18 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$428.70 B |
|
Lilly
|
$417.05 B |
|
Johnson & Johnson
|
$412.24 B |
Novo Nordisk
|
$329.83 B |
|
Merck
|
$275.82 B |
Company Description
GlaxoSmithKline PLC, better known as GSK, is a pharmaceutical company. GSK manufactures products for major disease areas such as asthma, cancer, infections, diabetes, and mental health, and it also has a portfolio of vaccines. Operating in more than 115 countries, GSK is also engaged in the consumer healthcare business in oral health, pain relief, respiratory, nutrition/gastro-intestinal, and skin health categories.
GlaxoSmithKline plc Categories
United Kingdom
languages
Healthcare
languages
Drug Manufacturers—General
United Kingdom Healthcare
United Kingdom Drug Manufacturers—General
What is a company's market capitalization?
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.